Study Evaluating Intermittent Dexcom G7 Glucose Monitoring with Support for Children and Teens Aged 10-19 with High-Risk Type 1 Diabetes in the Dominican Republic

What this Trial Is About

Researchers are studying children and adolescents aged 10 to 19 with high-risk type 1 diabetes in the Dominican Republic to see if intermittent use of the Dexcom G7 continuous glucose monitor CGM, combined with pediatric endocrinology follow-up, diabetes education, and psychological support, can improve glucose control. This pilot longitudinal study involves 40 participants from two pediatric diabetes care centers. Participants will use the Dexcom G7 CGM during two short monitoring periods early in the study, using six sensors in total. Between and after these monitoring periods, they will return to their usual finger-stick glucose monitoring with a glucometer. In addition, participants and their families will attend scheduled medical visits, diabetes education sessions, and psychological support sessions throughout the study. During the study, information will be collected from medical records, lab results, Dexcom Clarity reports, participant glucose logs, study forms, and questionnaires. Researchers will assess changes in HbA1c, time spent in glucose target range, average glucose levels, glucose variability, episodes of low and high blood glucose, adverse events, diabetes-related distress, fear of hypoglycemia, and satisfaction with glucose monitoring. The study lasts for 12 months with regular follow-up and support visits.

Continuous Glucose Monitoring in High-Risk Children and Youth With Type 1 Diabetes in the Dominican Republic